(Q26799652)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26238698%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

review article

1 reference

title

Malignant hyperthermia: a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26238698%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

main subject

malignant hyperthermia

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26238698%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Henry Rosenberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26238698%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Neil Pollock

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26238698%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Terasa Bulger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26238698%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Kathryn Stowell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26238698%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

English

0 references

publication date

4 August 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26238698%20AND%20SRC:MED&resulttype=core&format=json

Orphanet Journal of Rare Diseases

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26238698%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26238698%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

1

0 references

page(s)

93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26238698%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

20 February 2020

copyright license

start time

4 August 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Stac3 is a component of the excitation-contraction coupling machinery and mutated in Native American myopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

JP-45/JSRP1 variants affect skeletal muscle excitation-contraction coupling by decreasing the sensitivity of the dihydropyridine receptor

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Junctophilin 1 and 2 proteins interact with the L-type Ca2+ channel dihydropyridine receptors (DHPRs) in skeletal muscle

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Agonist-activated Ca2+ influx occurs at stable plasma membrane and endoplasmic reticulum junctions

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Junctin and the histidine-rich Ca2+ binding protein: potential roles in heart failure and arrhythmogenesis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Temperature monitoring and perioperative thermoregulation

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Central core disease: clinical, pathological, and genetic features

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Recommendations for returning genomic incidental findings? We need to talk!

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Disease mutations in the ryanodine receptor central region: crystal structures of a phosphorylation hot spot domain

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Mutations to Gly2370, Gly2373 or Gly2375 in malignant hyperthermia domain 2 decrease caffeine and cresol sensitivity of the rabbit skeletal-muscle Ca2+-release channel (ryanodine receptor isoform 1)

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Skeletal muscle-specific T-tubule protein STAC3 mediates voltage-induced Ca2+ release and contractility

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

An Ryr1I4895T mutation abolishes Ca2+ release channel function and delays development in homozygous offspring of a mutant mouse line

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

The junctional SR protein JP-45 affects the functional expression of the voltage-dependent Ca2+ channel Cav1.1

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

SIFT: Predicting amino acid changes that affect protein function

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Epigenetic changes as a common trigger of muscle weakness in congenital myopathies

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Next-generation Sequencing of RYR1 and CACNA1S in Malignant Hyperthermia and Exertional Heat Illness

9 May 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Stac adaptor proteins regulate trafficking and function of muscle and neuronal L-type Ca2+ channels

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Genetics professionals' opinions of whole-genome sequencing in the newborn period

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Genetic counselors' views and experiences with the clinical integration of genome sequencing

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Regulation of the skeletal muscle ryanodine receptor/Ca2+-release channel RyR1 by S-palmitoylation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

DNA testing for malignant hyperthermia: the reality and the dream

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Orai1-dependent calcium entry promotes skeletal muscle growth and limits fatigue

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Using exome data to identify malignant hyperthermia susceptibility mutations

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Exome sequencing reveals novel rare variants in the ryanodine receptor and calcium channel genes in malignant hyperthermia families

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Exertional heat stroke, rhabdomyolysis and susceptibility to malignant hyperthermia.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Unexpected MH deaths without exposure to inhalation anesthetics in pediatric patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Coverage bias and sensitivity of variant calling for four whole-genome sequencing technologies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Dantrolene-induced inhibition of skeletal L-type Ca2+ current requires RyR1 expression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Minimally invasive metabolic testing for malignant hyperthermia susceptibility: a systematic review of the methodology and results

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Ca2+ release in muscle fibers expressing R4892W and G4896V type 1 ryanodine receptor disease mutants

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Nonspecific sarcolemmal cation channels are critical for the pathogenesis of malignant hyperthermia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Sequence capture and massively parallel sequencing to detect mutations associated with malignant hyperthermia.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Temperature and RyR1 regulate the activation rate of store-operated Ca²+ entry current in myotubes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Type 1 ryanodine receptor knock-in mutation causing central core disease of skeletal muscle also displays a neuronal phenotype

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Gene dose influences cellular and calcium channel dysregulation in heterozygous and homozygous T4826I-RYR1 malignant hyperthermia-susceptible muscle

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Mice expressing T4826I-RYR1 are viable but exhibit sex- and genotype-dependent susceptibility to malignant hyperthermia and muscle damage

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Identical de novo mutation in the type 1 ryanodine receptor gene associated with fatal, stress-induced malignant hyperthermia in two unrelated families

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Genetic risk for malignant hyperthermia in non-anesthesia-induced myopathies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Dominant and recessive RYR1 mutations in adults with core lesions and mild muscle symptoms.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Malignant hyperthermia: pharmacology of triggering

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Activated charcoal effectively removes inhaled anesthetics from modern anesthesia machines

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Complications associated with the administration of dantrolene 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Sarcolemmal-restricted localization of functional ClC-1 channels in mouse skeletal muscle

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review

28 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

28 September 2017

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Store-operated Ca2+ entry in malignant hyperthermia-susceptible human skeletal muscle.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Effect of prior exercise on thermal sensitivity of malignant hyperthermia-susceptible muscle

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

A malignant hyperthermia-inducing mutation in RYR1 (R163C): alterations in Ca2+ entry, release, and retrograde signaling to the DHPR.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

A malignant hyperthermia-inducing mutation in RYR1 (R163C): consequent alterations in the functional properties of DHPR channels

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Functional studies of RYR1 mutations in the skeletal muscle ryanodine receptor using human RYR1 complementary DNA.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Functional properties of RYR1 mutations identified in Swedish patients with malignant hyperthermia and central core disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

The role of CACNA1S in predisposition to malignant hyperthermia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Automated inference of molecular mechanisms of disease from amino acid substitutions.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Functional annotations improve the predictive score of human disease-related mutations in proteins

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Inhalational anesthesia vs total intravenous anesthesia (TIVA) for pediatric anesthesia.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Calsequestrin-1: a new candidate gene for malignant hyperthermia and exertional/environmental heat stroke

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Checking your SOCCs and feet: the molecular mechanisms of Ca2+ entry in skeletal muscle

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

A retrograde signal from RyR1 alters DHP receptor inactivation and limits window Ca2+ release in muscle fibers of Y522S RyR1 knock-in mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Functional characterization of ryanodine receptor (RYR1) sequence variants using a metabolic assay in immortalized B-lymphocytes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

The skeletal L-type Ca(2+) current is a major contributor to excitation-coupled Ca(2+) entry

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

A recessive ryanodine receptor 1 mutation in a CCD patient increases channel activity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Postoperative malignant hyperthermia: an analysis of cases from the North American Malignant Hyperthermia Registry

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Reduced threshold for luminal Ca2+ activation of RyR1 underlies a causal mechanism of porcine malignant hyperthermia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

TRPC3-interacting triadic proteins in skeletal muscle

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Advanced technologies and devices for inhalational anesthetic drug dosing

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

SRP-27 is a novel component of the supramolecular signalling complex involved in skeletal muscle excitation-contraction coupling.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Triadin binding to the C-terminal luminal loop of the ryanodine receptor is important for skeletal muscle excitation contraction coupling

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Epigenetic allele silencing unveils recessive RYR1 mutations in core myopathies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Characterization of recessive RYR1 mutations in core myopathies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Mutations in RYR1 in malignant hyperthermia and central core disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Central core disease is due to RYR1 mutations in more than 90% of patients.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Ca2+ signaling in HEK-293 and skeletal muscle cells expressing recombinant ryanodine receptors harboring malignant hyperthermia and central core disease mutations.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Serotonin syndrome and other serotonergic disorders

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Fatal malignant hyperthermia-like syndrome with rhabdomyolysis complicating the presentation of diabetes mellitus in adolescent males

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Functional Defects in Six Ryanodine Receptor Isoform-1 (RyR1) Mutations Associated with Malignant Hyperthermia and Their Impact on Skeletal Excitation-Contraction Coupling

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Detection of proton release from cultured human myotubes to identify malignant hyperthermia susceptibility

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Heat stroke: implications for critical care and anaesthesia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Pathophysiological role of the serotonin system in malignant hyperthermia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Abnormal intracellular ca(2+)homeostasis and disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Malignant hyperthermia: advances in clinical management and diagnosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Ryanodine receptor mutations in malignant hyperthermia and central core disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

The sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: genotype-phenotype correlation.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Phosphorylation of serine 2843 in ryanodine receptor-calcium release channel of skeletal muscle by cAMP-, cGMP- and CaM-dependent protein kinase

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Malignant hyperthermia: a review of published cases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

A clinical grading scale to predict malignant hyperthermia susceptibility

28 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

28 September 2017

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Porcine malignant hyperthermia: critical temperatures for in vivo and in vitro responses.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Safe duration of postoperative monitoring for malignant hyperthermia patients administered non-triggering anaesthesia: an update.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

A novel device for target controlled administration and reflection of desflurane--the Mirus™.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Predicting functional effect of human missense mutations using PolyPhen-2.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Recessive RYR1 mutations cause unusual congenital myopathy with prominent nuclear internalization and large areas of myofibrillar disorganization

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Functional properties of ryanodine receptors carrying three amino acid substitutions identified in patients affected by multi-minicore disease and central core disease, expressed in immortalized lymphocytes

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

PMUT: a web-based tool for the annotation of pathological mutations on proteins.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

The calmodulin binding region of the skeletal ryanodine receptor acts as a self-modulatory domain

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Malignant hyperthermia and apparent heat stroke

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Results of in vitro contracture tests for the diagnosis of malignant hyperthermia susceptibility in monozygote twins.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Clinical reassessment of malignant hyperthermia in Abitibi-Témiscamingue.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Dyspedic mouse skeletal muscle expresses major elements of the triadic junction but lacks detectable ryanodine receptor protein and function

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Hyperkalemic cardiac arrest during anesthesia in infants and children with occult myopathies.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Rhabdomyolysis and acute renal failure in unsuspected malignant hyperpyrexia.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

The incidence of masseter muscle rigidity after succinylcholine in infants and children

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Masseter spasm with anesthesia: incidence and implications

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Anesthetic-induced malignant hyperpyrexia in children.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Incidence of malignant hyperthermia in Denmark

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Hyperkalemia, verapamil, and dantrolene

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

The role of sympathetic activity in initiating malignant hyperthermia

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Muscle activity, pH and malignant hyperthermia.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Anesthesia in malignant hyperthermia susceptible patients.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Fatty acids markedly lower the threshold for halothane-induced calcium release from the terminal cisternae in human and porcine normal and malignant hyperthermia susceptible skeletal muscle.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Prediction of malignant hyperthermia susceptibility in low-risk subjects. An epidemiologic investigation of caffeine halothane contracture responses. The North American Malignant Hyperthermia Registry.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Anaesthetic uptake and washout characteristics of patient circuit tubing with special regard to current decontamination techniques

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Prevalence of malignant hyperthermia due to anesthesia in New York State, 2001-2005.

31 May 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Malignant hyperthermia in infancy and identification of novel RYR1 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Multiple interacting gene products may influence susceptibility to malignant hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

John H. Eisenach, M.D., recipient of the 2008 Presidential Scholar Award

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Delayed postoperative rhabdomyolysis in a patient subsequently diagnosed as malignant hyperthermia susceptible

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Volatile isoflurane sedation in cerebrovascular intensive care patients using AnaConDa(®): effects on cerebral oxygenation, circulation, and pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Short-term sevoflurane sedation using the Anaesthetic Conserving Device after cardiothoracic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Health worker exposure risk during inhalation sedation with sevoflurane using the (AnaConDa®) anaesthetic conserving device

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Malignant hyperthermia on ICU – sudden attack of the “snake”.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

King-denborough syndrome caused by a novel mutation in the ryanodine receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

King–Denborough syndrome with and without mutations in the skeletal muscle ryanodine receptor (RYR1) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the north american population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Junctate, an inositol 1,4,5-triphosphate receptor associated protein, is present in rodent sperm and binds TRPC2 and TRPC5 but not TRPC1 channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

N-terminal region of FKBP12 is essential for binding to the skeletal ryanodine receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Exertional rhabdomyolysis and malignant hyperthermia in a patient with ryanodine receptor type 1 gene, L-type calcium channel alpha-1 subunit gene, and calsequestrin-1 gene polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Stress-induced increase in skeletal muscle force requires protein kinase A phosphorylation of the ryanodine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

S-glutathionylation decreases Mg2+ inhibition and S-nitrosylation enhances Ca2+ activation of RyR1 channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Masseter muscle rigidity associated with glycine1306-to-alanine mutation in the adult muscle sodium channel alpha-subunit gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Ca2+ store determines gating of store operated calcium entry in mammalian skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

STIM1 negatively regulates Ca²⁺ release from the sarcoplasmic reticulum in skeletal myotubes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Muscle biopsy and in vitro contracture test in subjects with idiopathic HyperCKemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Prediction of Malignant Hyperthermia Susceptibility in Low-risk Subjects An Epidemiologic Investigation of Caffeine Halothane Contracture Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Sevoflurane is less sensitive than halothane for in vitro detection of malignant hyperthermia susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Identification and biochemical characterization of a novel ryanodine receptor gene mutation associated with malignant hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Functional characterization of 2 known ryanodine receptor mutations causing malignant hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Two central core disease (CCD) deletions in the C-terminal region of RYR1 alter muscle excitation-contraction (EC) coupling by distinct mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Ascending tonic-clonic syndrome secondary to intrathecal Omnipaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Hyperkalemic cardiac arrest after cardiopulmonary bypass in a child with unsuspected duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Categorizing genetic tests to identify their ethical, legal, and social implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

The psychological dimension of informed consent: dissonance processes in genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Malignant hyperthermia: human stress triggering

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Serotonin toxicity and malignant hyperthermia: role of 5-HT2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Malignant hyperthermia associated with exercise-induced rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation in New Zealand and Australian pedigrees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Epigenetic allele silencing and variable penetrance of malignant hyperthermia susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Cardiac arrests and deaths associated with malignant hyperthermia in north america from 1987 to 2006: a report from the north american malignant hyperthermia registry of the malignant hyperthermia association of the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

Clarifying the role of activated charcoal filters in preparing an anaesthetic workstation for malignant hyperthermia-susceptible patients.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

CASQ1 gene is an unlikely candidate for malignant hyperthermia susceptibility in the North American population

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Preparation of Datex-Ohmeda Aestiva and Aisys anaesthetic machines for use in malignant hyperthermia susceptible patients.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Molecular genetic detection of susceptibility to malignant hyperthermia in Belgian families

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Suspected malignant hyperthermia reactions in New Zealand.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Improved noninvasive diagnostic testing for malignant hyperthermia susceptibility from a combination of metabolites determined in vivo with 31P-magnetic resonance spectroscopy.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Malignant hyperthermia: halothane- and calcium-induced calcium release in skeletal muscle

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Human malignant hyperthermia: awake episodes and correction by dantrolene.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Malignant hyperthermia: slow sodium current in cultured human muscle cells.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4524368

Next-generation DNA sequencing of a Swedish malignant hyperthermia cohort

28 November 2018

1 reference

12 December 2020

Heat stroke and malignant hyperpyrexia

1 reference

12 December 2020

A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group

1 reference

12 December 2020

Lessons from calsequestrin-1 ablation in vivo: much more than a Ca(2+) buffer after all

1 reference

12 December 2020

Malignant hyperthermia

1 reference

12 December 2020

Ryanodinopathies: RyR-Linked Muscle Diseases

1 reference

12 December 2020

Malignant hyperthermia and central core disease causative mutations in Swedish patients

1 reference

12 December 2020

Native American myopathy: congenital myopathy with cleft palate, skeletal anomalies, and susceptibility to malignant hyperthermia

1 reference

12 December 2020

Hemodynamic and metabolic alterations in response to graded exercise in a patient susceptible to malignant hyperthermia

1 reference

12 December 2020

Dantrolene in malignant hyperthermia (MH)-susceptible patients with exaggerated exercise stress

1 reference

12 December 2020

Malignant hyperthermia

1 reference

12 December 2020

Perioperative severe rhabdomyolysis revealing susceptibility to malignant hyperthermia

1 reference

12 December 2020

A multicenter study of 4-chloro-m-cresol for diagnosing malignant hyperthermia susceptibility

1 reference

12 December 2020

In vivo and in vitro characterization of skeletal muscle metabolism in patients with statin-induced adverse effects

1 reference

12 December 2020

Malignant hyperthermia masked by capnographic monitoring

1 reference

12 December 2020

Skeletal muscle ryanodine receptor mutations associated with malignant hyperthermia showed enhanced intensity and sensitivity to triggering drugs when expressed in human embryonic kidney cells

1 reference

12 December 2020

[Helsinki Declaration on Patient Safety in Anaesthesiology - Part 3: SOP for malignant hyperthermia]

1 reference

12 December 2020

Endocrine and metabolic disorders in anaesthesia and intensive care

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

7 January 2021

inferred from DOI database lookup

Should we use muscle biopsy to diagnose malignant hyperthermia susceptibility?

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0310-1

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1186/S13023-015-0310-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26238698%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26238698%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

PubMed publication ID

26238698

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26238698%20AND%20SRC:MED&resulttype=core&format=json